1
项与 MIDRIXNEO-LUNG DCs(Ghent University Hospital) 相关的临床试验Phase Ia Study of MIDRIX4-LUNG, a Tetravalent Autologous Dendritic Cell Vaccine, in Patients With Metastatic Non-small Cell Lung Cancer
MIDRIX4-LUNG is a novel tetravalent autologous dendritic cell vaccine in metastatic non-small cell lung cancer patients. This first-in-human study aims to primarily establish maximal tolerated dose of MIDRIX4-LUNG administered i.v.
100 项与 MIDRIXNEO-LUNG DCs(Ghent University Hospital) 相关的临床结果
100 项与 MIDRIXNEO-LUNG DCs(Ghent University Hospital) 相关的转化医学
100 项与 MIDRIXNEO-LUNG DCs(Ghent University Hospital) 相关的专利(医药)
100 项与 MIDRIXNEO-LUNG DCs(Ghent University Hospital) 相关的药物交易